Flurry of Medical Device IPOS Drive High Valuations
March 12, 2014
What do Biomet, Lombard Medical, Trivascular, Lumenis have in common. These companies are  filing IPO.
In January of 2014 we saw investment bankers starting to show interest in pre-revenue and revenue generating  medical device companies exploring IPO opportunity.
Medical device companies have always been sitting on the side lines when it comes to filing IPO, many companies did not use IPO as a source of exit or growth opportunity. Typically, these medical device companies would get acquired by a large strategic players.

More IB are realizing that the medical device sector has a very predictable regulatory path and faster commercialization capabilities than biotech and pharma sector. Medical device market in emerging countries is expanding rapidly. Investors appreciate that the exits in the device sector may not be very large but more predictable and quick. Investors seeing to make a quick buck will follow medical devices, those wanting to wait a decade for a payoff will be pro-biotech.

Today, the momentum of pre-revenue medical device IPO is growing. Sectors that are very hot are obesity , diabetes, sleep apnea, ENT, orthopedics and low cost spine surgery options.